{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T17:55:42Z","timestamp":1696614942142},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00108-011-2924-2","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T05:46:45Z","timestamp":1321422405000},"page":"1394-1406","source":"Crossref","is-referenced-by-count":2,"title":["Therapie der autoimmunen Lebererkrankungen"],"prefix":"10.1007","volume":"52","author":[{"given":"C.P.","family":"Strassburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"2924_CR1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","volume":"45","author":"Al-Chalabi","year":"2006","unstructured":"Al-Chalabi T, Boccato S, Portmann BC et al (2006) Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 45:575\u2013583","journal-title":"J Hepatol"},{"key":"2924_CR2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000213364","volume":"79","author":"Alderlieste","year":"2009","unstructured":"Alderlieste YA, Van Den Elzen BD, Rauws EA et al (2009) Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease. Digestion 79:220\u2013228","journal-title":"Digestion"},{"key":"2924_CR3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatology 31:929\u2013938","journal-title":"J Hepatology"},{"key":"2924_CR4","doi-asserted-by":"crossref","unstructured":"Barr Fritcher EG, Kipp BR, Voss JS et al (2011) Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol [Epub ahead of print]","DOI":"10.1038\/ajg.2011.272"},{"key":"2924_CR5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","volume":"18","author":"Bjornsson","year":"2010","unstructured":"Bjornsson E, Chari S, Silveira M et al (2010) Primary sclerosing cholangitis associated with elevated immunoglobulin G4: Clinical characteristics and response to therapy. Am J Ther 18:198\u2013205","journal-title":"Am J Ther"},{"key":"2924_CR6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A et al (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:660\u2013678","journal-title":"Hepatology"},{"key":"2924_CR7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","volume":"33","author":"Culver","year":"2011","unstructured":"Culver EL, Chapman RW (2011) Systematic review: management options for primary sclerosing cholangitis and its variant forms \u2013 IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther 33:1273\u20131291","journal-title":"Aliment Pharmacol Ther"},{"key":"2924_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP (2010) Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 139:58\u201372 e54","journal-title":"Gastroenterology"},{"key":"2924_CR9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","volume":"95","author":"Czaja","year":"1988","unstructured":"Czaja AJ, Rakela J, Ludwig J (1988) Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 95:448\u2013453","journal-title":"Gastroenterology"},{"key":"2924_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","volume":"8","author":"Danielson","year":"1994","unstructured":"Danielson A, Prytz H (1994) Oral budesonide for treatment of autoimmune chronic hepatitis. Aliment Pharmacol Ther 8:585\u2013590","journal-title":"Aliment Pharmacol Ther"},{"key":"2924_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European","year":"2009","unstructured":"European Association for the Study of the Liver (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51:237\u2013267","journal-title":"J Hepatol"},{"key":"2924_CR12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1572-0241.2007.01118.x","volume":"102","author":"Gelbmann","year":"2007","unstructured":"Gelbmann CM, Rummele P, Wimmer M et al (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102:1221\u20131229","journal-title":"Am J Gastroenterol"},{"key":"2924_CR13","first-page":"CD004036","volume":"Rev","author":"Giljaca","year":"2010","unstructured":"Giljaca V, Poropat G, Stimac D et al (2010) Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev: CD004036","journal-title":"Cochrane Database Syst"},{"key":"2924_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2009.10.041","volume":"71","author":"Gotthardt","year":"2010","unstructured":"Gotthardt DN, Rudolph G, Kloters-Plachky P et al (2010) Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 71:527\u2013534","journal-title":"Gastrointest Endosc"},{"key":"2924_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","volume":"38","author":"Hempfling","year":"2003","unstructured":"Hempfling W, Grunhage F, Dilger K et al (2003) Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 38:196\u2013202","journal-title":"Hepatology"},{"key":"2924_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169\u2013176","journal-title":"Hepatology"},{"key":"2924_CR17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0031-1276647","volume":"31","author":"Karlsen","year":"2011","unstructured":"Karlsen TH, Kaser A (2011) Deciphering the genetic predisposition to primary sclerosing cholangitis. Semin Liver Dis 31:188\u2013207","journal-title":"Semin Liver Dis"},{"key":"2924_CR18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","volume":"53","author":"Lankisch","year":"2011","unstructured":"Lankisch TO, Metzger J, Negm AA et al (2011) Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 53:875\u2013884","journal-title":"Hepatology"},{"key":"2924_CR19","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD et al (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51:2193\u20132213","journal-title":"Hepatology"},{"key":"2924_CR20","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","volume":"120","author":"Manns","year":"2001","unstructured":"Manns MP, Strassburg CP (2001) Autoimmune hepatitis: clinical challenges. Gastroenterology 120:1502\u20131517","journal-title":"Gastroenterology"},{"key":"2924_CR21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W et al (2010) Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 139:1198\u20131206","journal-title":"Gastroenterology"},{"key":"2924_CR22","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","volume":"53","author":"Molodecky","year":"2011","unstructured":"Molodecky NA, Kareemi H, Parab R et al (2011) Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 53:1590\u20131599","journal-title":"Hepatology"},{"key":"2924_CR23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.gie.2010.02.043","volume":"72","author":"Negm","year":"2010","unstructured":"Negm AA, Schott A, Vonberg RP et al (2010) Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 72:284\u2013291","journal-title":"Gastrointest Endosc"},{"key":"2924_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.gie.2010.02.043","volume":"72","author":"Negm","year":"2011","unstructured":"Negm AA, Schott A, Vonberg RP et al (2011) Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 72:284\u2013291","journal-title":"Gastrointest Endosc"},{"key":"2924_CR25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, De Muckadell OS et al (2005) High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129:1464\u20131472","journal-title":"Gastroenterology"},{"key":"2924_CR26","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/j.1572-0241.1999.01364.x","volume":"94","author":"Ponsioen","year":"1999","unstructured":"Ponsioen CY, Lam K, Van Milligen De Wit Aw et al (1999) Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 94:2403\u20132407","journal-title":"Am J Gastroenterol"},{"key":"2924_CR27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0030-1255527","volume":"42","author":"Ponsioen","year":"2010","unstructured":"Ponsioen CY, Reitsma JB, Boberg KM et al (2010) Validation of a cholangiographic prognostic model in primary sclerosing cholangitis. Endoscopy 42:742\u2013747","journal-title":"Endoscopy"},{"key":"2924_CR28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","volume":"21","author":"Rowe","year":"2008","unstructured":"Rowe IA, Webb K, Gunson BK et al (2008) The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 21:459\u2013465","journal-title":"Transpl Int"},{"key":"2924_CR29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","volume":"51","author":"Rudolph","year":"2009","unstructured":"Rudolph G, Gotthardt D, Kloters-Plachky P et al (2009) Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 51:149\u2013155","journal-title":"J Hepatol"},{"key":"2924_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrgastro.2009.46","volume":"6","author":"Ruemmele","year":"2009","unstructured":"Ruemmele P, Hofstaedter F, Gelbmann CM (2009) Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 6:287\u2013295","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2924_CR31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","volume":"36","author":"Stiehl","year":"2002","unstructured":"Stiehl A, Rudolph G, Kloters-Plachky P et al (2002) Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 36:151\u2013156","journal-title":"J Hepatol"},{"key":"2924_CR32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bpg.2010.07.011","volume":"24","author":"Strassburg","year":"2010","unstructured":"Strassburg CP (2010) Autoimmune hepatitis. Best Pract Res Clin Gastroenterol 24:667\u2013682","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2924_CR33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2003-40161","volume":"128","author":"Strassburg","year":"2003","unstructured":"Strassburg CP, Manns MP (2003) Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis. Dtsch Med Wochenschr 128 (Suppl 2):96\u201398","journal-title":"Dtsch Med Wochenschr"},{"key":"2924_CR34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-2006-951599","volume":"26","author":"Strassburg","year":"2006","unstructured":"Strassburg CP, Manns MP (2006) Approaches to liver biopsy techniques \u2013 revisited. Semin Liver Dis 26:318\u2013327","journal-title":"Semin Liver Dis"},{"key":"2924_CR35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhep.2006.07.008","volume":"45","author":"Strassburg","year":"2006","unstructured":"Strassburg CP, Manns MP (2006) Autoimmune hepatitis in the elderly: what is the difference? J Hepatol 45:480\u2013482","journal-title":"J Hepatol"},{"key":"2924_CR36","unstructured":"Strassburg CP, Manns MP (2009) Liver transplantation: indications and results. Internist (Berl) 50:550\u2013560"},{"key":"2924_CR37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0029-1233534","volume":"29","author":"Strassburg","year":"2009","unstructured":"Strassburg CP, Manns MP (2009) Treatment of autoimmune hepatitis. Semin Liver Dis 29:273\u2013285","journal-title":"Semin Liver Dis"},{"key":"2924_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1385\/CRIAI:18:2:127","volume":"18","author":"Strassburg","year":"2000","unstructured":"Strassburg CP, Obermayer-Straub P, Manns MP (2000) Autoimmunity in liver diseases. Clin Rev Allergy Immunol 18:127\u2013139","journal-title":"Clin Rev Allergy Immunol"},{"key":"2924_CR39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","volume":"36","author":"Terjung","year":"2009","unstructured":"Terjung B, Spengler U (2009) Atypical p-ANCA in PSC and AIH: a hint toward a \u201eleaky gut\u201c? Clin Rev Allergy Immunol 36:40\u201351","journal-title":"Clin Rev Allergy Immunol"},{"key":"2924_CR40","first-page":"1687","volume":"29","author":"Thalen","year":"1979","unstructured":"Thalen A, Brattsand R (1979) Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity. Arzneimittelforschung 29:1687\u20131690","journal-title":"Arzneimittelforschung"},{"key":"2924_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","volume":"102","author":"Tischendorf","year":"2007","unstructured":"Tischendorf JJ, Hecker H, Kruger M et al (2007) Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol 102:107\u2013114","journal-title":"Am J Gastroenterol"},{"key":"2924_CR42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/00365520600633495","volume":"41","author":"Tischendorf","year":"2006","unstructured":"Tischendorf JJ, Meier PN, Strassburg CP et al (2006) Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scand J Gastroenterol 41:1227\u20131234","journal-title":"Scand J Gastroenterol"},{"key":"2924_CR43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2036.2011.04753.x","volume":"34","author":"Torres","year":"2011","unstructured":"Torres J, De Chambrun Gp, Itzkowitz S et al (2011) Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther 34:497\u2013508","journal-title":"Aliment Pharmacol Ther"},{"key":"2924_CR44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","volume":"18","author":"Vogel","year":"2004","unstructured":"Vogel A, Heinrich E, Bahr MJ et al (2004) Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 18:62\u201369","journal-title":"Clin Transplant"},{"key":"2924_CR45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(08)60245-7","volume":"48","author":"Weism\u00fcller","year":"2008","unstructured":"Weism\u00fcller TJ, Wedemeyer J, Kubicka S et al (2008) The challenges in primary sclerosing cholangitis \u2013 Aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48:38\u201357","journal-title":"J Hepatol"},{"key":"2924_CR46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","volume":"25","author":"Wiegand","year":"2005","unstructured":"Wiegand J, Schuler A, Kanzler S et al (2005) Budesonide in previously untreated autoimmune hepatitis. Liver Int 25:927\u2013934","journal-title":"Liver Int"},{"key":"2924_CR47","doi-asserted-by":"crossref","unstructured":"Wiencke K, Boberg KM (2011) Current consensus on the management of primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol [Epub ahead of print]","DOI":"10.1016\/j.clinre.2011.04.007"},{"key":"2924_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11894-009-0079-2","volume":"12","author":"Zein","year":"2010","unstructured":"Zein CO, Lindor KD (2010) Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis. Curr Gastroenterol Rep 12:13\u201322","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-011-2924-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-011-2924-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-011-2924-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T15:56:34Z","timestamp":1560959794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-011-2924-2"}},"subtitle":["Autoimmune Hepatitis, prim\u00e4r sklerosierende Cholangitis"],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1007\/s00108-011-2924-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}